September 24, 2025 - 17:22

Mark A. Peterson has been awarded the inaugural Career Achievement Award by the American Political Science Association (APSA), recognizing his extensive contributions to the fields of health politics and policy. This prestigious accolade celebrates Peterson's decades-long commitment to scholarship, mentorship, and his significant impact on the discipline.
Throughout his career, Peterson has been a leading voice in health policy discussions, influencing both academic and public spheres. His research has shaped understanding of the complex interactions between politics and health care, making him a pivotal figure in the study of these critical areas. As a mentor, he has guided numerous students and emerging scholars, fostering a new generation of experts in health politics.
The APSA award highlights not only Peterson's individual achievements but also underscores the importance of health politics as a vital area of study within political science. His work continues to inspire colleagues and students alike, solidifying his legacy in the field.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....